Physician
Cardiology
Dr. Steven Borzak, MD
|
|
Give Review
Steven Borzak works in the field of Cardiology. He went to medical school at University of Illinois College of Medicine. He has 5 awards "Gulfstream FL-Palm Beach", "America's Top Doctors", "SouthFloridaCEO: Top Doctors", "Top Doctors: Florida" and "Fellow (FACC)". Steven Borzak is a published MD. He published 97 publications, including: 'Lower thrombolytic use for African Americans with myocardial infarction: an influence of clinical presentation?' Steven Borzak accepts Medicare payments and is registered with Medicare.gov.
Publications
- Non-critical care telemetry and in-hospital cardiac arrest outcomes.
- Cardiovascular risks of cyclooxygenase-2 inhibitors and traditional anti-inflammatory drugs: necessary but not sufficient for clinical decision making.
- The case for generic statins: not if they don't work so well.
- Aspirin Increases Nitric Oxide Formation in Chronic Stable Coronary Disease.
- Very late subacute thrombosis of a sirolimus-eluting stent after 57 months.
- ACP Journal Club: Early transfer for angiography after fibrinolysis reduced ischemic events in patients with STEMI.
- ACP Journal Club. Fondaparinux led to less bleeding than enoxaparin in patients with non-ST-elevation acute coronary syndromes.
- Pharmacokinetics of ibutilide in patients with heart failure due to left ventricular systolic dysfunction.
- Cyclooxygenase-2 inhibitors and most traditional nonsteroidal anti-inflammatory drugs cause similar moderately increased risks of cardiovascular disease.
- Preliminary experience with intravenous P2Y12 platelet receptor inhibition as an adjunct to reduced-dose alteplase during acute myocardial infarction: results of the S...
- Brain natriuretic peptide: clinical and research challenges.
- Hemodynamic and neurohormonal predictors and consequences of the development of atrial fibrillation in dogs with chronic heart failure.
- Funding of clinical trials.
- Fondaparinux reduced death or reinfarction in acute ST-segment elevation myocardial infarction.
- Clopidogrel before percutaneous coronary intervention reduced cardiovascular outcome in ST-elevation myocardial infarction.
- Administrative data feedback failed to improve quality of care in acute myocardial infarction.
- An early invasive strategy improved long-term freedom from major adverse cardiac events in older patients with angina.
- The impact of arrhythmias in acute heart failure.
- Risk factors for hypertensive crisis: importance of out-patient blood pressure control.
- Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: pri...
- A disease management program reduced hospital readmission days after myocardial infarction.
- Relation of age and race with hospital death after acute myocardial infarction.
- Influence of i.v. haloperidol on ventricular repolarization and monophasic action potential duration in anesthetized dogs.
- Single lead ST-segment recovery: a simple, reliable measure of successful fibrinolysis after acute myocardial infarction.
- Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes.
- Use of discharge-worksheet enhances compliance with evidence-based myocardial infarction care.
- Bleeding associated with eptifibatide targeting higher risk patients with acute coronary syndromes: incidence and multivariate risk factors.
- Medication errors in acute cardiac care: An American Heart Association scientific statement from the Council on Clinical Cardiology Subcommittee on Acute Cardiac Care,...
- Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofi...
- Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease.
- The independent association of renal dysfunction and arrhythmias in critically ill patients.
- Perceptions of chest pain differ by race.
- An early invasive strategy was effective in the acute coronary syndrome with elevated cardiac troponin I and T levels.
- Cardiovascular outcomes and renal disease.
- Improving quality of care for acute myocardial infarction: The Guidelines Applied in Practice (GAP) Initiative.
- Abciximab did not reduce death or myocardial infarction in the acute coronary syndrome without early revascularization.
- Tenecteplase plus enoxaparin or abciximab was better than tenecteplase plus unfractionated heparin for acute MI.
- Reteplase plus abciximab and reteplase alone led to similar 30-day mortality rates in acute MI.
- TIMI myocardial perfusion grade and ST segment resolution: association with infarct size as assessed by single photon emission computed tomography imaging.
- Double-blind, randomized trial of an anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction: limitation of myo...
- Underutilization of reperfusion therapy in eligible African Americans with acute myocardial infarction: Role of presentation and evaluation characteristics.
- Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I.
- Pharmacologic conversion of atrial fibrillation: a systematic review of available evidence.
- Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction.
- How safely and for how long can warfarin therapy be withheld in prosthetic heart valve patients hospitalized with a major hemorrhage?
- Regular review: treatment possibilities for unstable angina.
- Sex and outcome after myocardial infarction: A case of sexual politics?
- Effect of delay on racial differences in thrombolysis for acute myocardial infarction.
- Risks associated with renal dysfunction in patients in the coronary care unit.
- Electrocardiographic presentation of blacks with first myocardial infarction does not explain race differences in thrombolysis administration.
- Myocarditis and pericarditis with tamponade associated with disseminated tuberculosis.
- Hemodynamic effects of a novel sodium channel activator in dogs with chronic heart failure.
- Combination therapy with tirofiban and enoxaparin in acute coronary syndromes.
- Key references: Role of ACE inhibition in acute coronary syndromes.
- No time to wait.
- Treatment of postoperative atrial fibrillation.
- Low-molecular-weight heparins in the management of acute coronary syndromes.
- Medical therapy of acute myocardial infarction: Part I. Role of thrombolytic and antithrombotic therapy.
- Medical therapy of acute myocardial infarction: Part II. The role of adjunctive medical therapy.
- Sinus bradycardia and multiple episodes of sinus arrest following administration of ibutilide.
- Lower thrombolytic use for African Americans with myocardial infarction: an influence of clinical presentation?
- A randomized, multicenter trial of weight-adjusted intravenous heparin dose titration and point-of-care coagulation monitoring in hospitalized patients with active thr...
- Effect of payer status on outcomes of coronary artery bypass surgery in blacks.
- Quality of history taking in patients with aortic dissection.
- Role of antiarrhythmic agents after myocardial infarction with special reference to the EMIAT and CAMIAT trials of amiodarone. European Myocardial Infarct Amiodarone T...
- Atrial fibrillation after bypass surgery: does the arrhythmia or the characteristics of the patients prolong hospital stay?
- A randomized, double-blind comparison of intravenous diltiazem and digoxin for atrial fibrillation after coronary artery bypass surgery.
- Short-term hemodynamic effects of mibefradil in dogs with chronic heart failure: comparison with diltiazem.
- Effects of prior aspirin and anti-ischemic therapy on outcome of patients with unstable angina. TIMI 7 Investigators. Thrombin Inhibition in Myocardial Ischemia.
- Prevention of peripheral venous catheter complications with an intravenous therapy team: a randomized controlled trial.
- Randomized trial of an oral platelet glycoprotein IIb/IIIa antagonist, sibrafiban, in patients after an acute coronary syndrome: results of the TIMI 12 trial. Thrombol...
- Usefulness of intravenous magnesium for multifocal atrial tachycardia in patients with chronic obstructive pulmonary disease.
- Multifocal atrial tachycardia.
- Intravenous clofilium for conversion of atrial fibrillation.
- Disposition of procainamide in patients with chronic congestive heart failure receiving medical therapy.
- Angiotensin-converting enzyme inhibition after acute myocardial infarction with special reference to the Fourth International Study of Infarct Survival (ISIS-4).
- Inhibition of N-acetylation of procainamide and renal clearance of N-acetylprocainamide by para-aminobenzoic acid in humans.
- "Inadvertent" thrombolytic administration in patients without myocardial infarction: clinical features and outcome.
- Short-term hemodynamic effects of endothelin receptor blockade in dogs with chronic heart failure.
- Decline in the rate of hospital mortality from acute myocardial infarction: impact of changing management strategies.
- Discordance between effects of anti-ischemic therapy on ambulatory ischemia, exercise performance and anginal symptoms in patients with stable angina pectoris. The Ang...
- Cumulative meta-analyses and the problem of multiple drug effects.
- Role of cation gradients in hypercontracture of myocytes during simulated ischemia and reperfusion.
- Thrombolytic therapy for unstable angina.
- Early intravenous beta-blocker combined with thrombolytic therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI-2) Trial.
- Magnesium for myocardial infarction?
- Psychosocial factors related to unrecognized acute myocardial infarction.
- Proarrhythmic effects of intravenous vasopressors.
- Electrophysiologic and proarrhythmic effects of intravenous inotropic agents.
- Discordance between meta-analyses and large-scale randomized, controlled trials. Examples from the management of acute myocardial infarction.
- In situ calibration of fura-2 and BCECF fluorescence in adult rat ventricular myocytes.
- Mechanisms of rate staircase in rat ventricular cells.
- Non-Q wave myocardial infarction.
- Intravenous nitroglycerin for acute myocardial infarction.
- Na+ efflux mechanisms in ventricular myocytes: measurement of [Na+]i with Na(+)-binding benzofuran isophthalate.
- Doing more good than harm: need for a cease fire.
Schools
University Of Illinois College Of Medicine Chicago
Michael Reese Hospital
Brigham and Womens Hospital Harvard Med School
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Gulfstream FL-Palm Beach
- America's Top Doctors
- SouthFloridaCEO: Top Doctors
- Top Doctors: Florida
- Fellow (FACC)
Education
-
Brigham and Women's Hospital -
University of Illinois College of Medicine
Hospital
-
JFK Medical Center
Drug Facts
| NPI NUMBER | 1427031848 | |
| NPPES Provider LastName | BORZAK | |
| NPPES Provider FirstName | STEVEN | |
| NPPES Provider ZIPCode | 334621146 | |
| NPPES Provider State | FL | |
| Specialty Description | Cardiology | |
| Total Claim Count | 5068.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1427031848 |
| Last Name Of The Provider | BORZAK |
| First Name Of The Provider | STEVEN |
| View All |
Similar Doctors
|
Dr. Joel P. Gordon, MD |
|
Dr. Carmen Torres, MD |
|
Dr. Rizwan A. Karatela, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Vladimir Rankovic, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Hedayatollah E. Zaghi, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Mark Freher, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Terrence J. Cohen, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Benjamin Sakethou, MD |
|
|
Dr. Allan Wald, MD
This Doctor is OpenDoctor Recommended.
|